Are Replicel the real deal?

[crafter]

VANCOUVER, BC - January 2, 2014 - RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCQB: REPCF) (CNSX: RP) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the "TSXV") for the listing of its common shares on the TSXV. The listing is subject to the Company fulfilling certain requirements of the TSXV in accordance with the terms of the conditional approval. Upon obtaining final approval, the Company will issue a further press release to update when it anticipates its common shares will commence trading on the TSXV. In connection with the Company's listing on the TSXV, the Company anticipates that 23,509,682 shares of its common stock (each, a "Share"), which represents approximately 49% of the Company's issued and outstanding shares, will be escrowed, with 25% of the escrowed Shares being released upon listing and a further 25% every six months. In addition, stock options to acquire up to 1,400,000 Shares will also be subject to escrow under the same release schedule.

[Jotronic]

The real deal in what way? They are trying to increase their monetization so they can continue their research. Eventually, they hope to be bought out and this is the best way to achieve those goals.

[crafter]

real deal as in that their treatment will really work?

 

they seem to be doing well at getting backing despite the not so impressive results from phase 1.

[Jotronic]

In my opinion, they are the real deal in that they have some smart people working there and they are legitimate with their efforts but I personally don't think they are any closer than anyone else at the holy grail. They are one of the leaders but only because the field of players seems to be getting smaller.